Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

NCT03651102 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

654

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia

Interventions

DRUG: Thalidomide and Hydroxyurea

Sponsor

Blood Diseases Clinic

Collaborators

[object Object]